Your Biomarkers, Claude's Context
Paid lab memberships meet LLM integration
Function announced a "Function Connector for Claude," letting members authorize Claude to access their lab data via Function. The AI can then respond with guidance grounded in a member's results rather than generic advice. This turns the LLM into a concierge interpreter of expensive testing—your personal AI that knows your numbers.
The Regulatory Backdrop
Where does "explain my labs" end and "medical advice" begin? FDA guidance on clinical decision support software clarifies which functions are regulated as medical devices; some decision-support functions remain regulated depending on intended use and context.
This regulatory ambiguity shapes the industry. Products positioned as wellness tools face lighter oversight than products making diagnostic claims. The language matters: "helping you understand your data" differs legally from "recommending treatment." Function and similar services navigate this boundary carefully.
Why It Matters for Luxury
Function represents "AI as a luxury layer on top of your own data." The service isn't just lab testing—it's lab testing plus interpretation plus conversational interface plus ongoing relationship. The membership model creates recurring revenue while the AI integration provides differentiation. When your AI knows your biomarkers, generic health chatbots feel inadequate by comparison.
Product / Brand Links
News & Coverage
- PR Newswire: Function launches integration with Claude — December 2025
- Anthropic: Healthcare and life sciences — Claude partnerships and health data integrations — February 2024
- FDA: Clinical decision support software guidance — January 2026